Fuller & Thaler Asset Management Inc. Makes New $532,000 Investment in AdaptHealth Corp. $AHCO

Key Points

• Fuller & Thaler Asset Management Inc. acquired a new stake in AdaptHealth Corp. worth approximately $532,000, purchasing 49,115 shares in the first quarter.
• AdaptHealth's stock is currently down 1.3%, trading at $9.33, with a 12-month range of $7.11 to $11.70, and an average consensus rating of "Buy" among analysts.
• Institutional investors own 82.67% of AdaptHealth's stock, with notable increases in holdings from GAMMA Investing LLC and Brooklyn Investment Group during the first quarter.

Fuller & Thaler Asset Management Inc. purchased a new stake in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) in the first quarter, according to its most recent disclosure with the SEC. The firm purchased 49,115 shares of the company's stock, valued at approximately $532,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Brooklyn Investment Group boosted its stake in AdaptHealth by 531.8% during the 1st quarter. Brooklyn Investment Group now owns 7,563 shares of the company's stock valued at $82,000 after purchasing an additional 6,366 shares in the last quarter. American Century Companies Inc. boosted its stake in AdaptHealth by 13.7% during the 1st quarter. American Century Companies Inc. now owns 239,143 shares of the company's stock valued at $2,592,000 after purchasing an additional 28,784 shares in the last quarter. Russell Investments Group Ltd. boosted its stake in AdaptHealth by 96.5% during the 1st quarter. Russell Investments Group Ltd. now owns 383,464 shares of the company's stock valued at $4,157,000 after purchasing an additional 188,293 shares in the last quarter. Public Sector Pension Investment Board boosted its stake in AdaptHealth by 27.3% during the 1st quarter. Public Sector Pension Investment Board now owns 336,876 shares of the company's stock valued at $3,652,000 after purchasing an additional 72,174 shares in the last quarter. Finally, Nuveen LLC bought a new position in AdaptHealth during the 1st quarter valued at $3,427,000. 82.67% of the stock is owned by institutional investors.

AdaptHealth Stock Down 0.8%

Shares of NASDAQ:AHCO traded down $0.08 during midday trading on Tuesday, hitting $9.16. 119,358 shares of the stock were exchanged, compared to its average volume of 1,418,909. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.82 and a current ratio of 1.06. AdaptHealth Corp. has a 52-week low of $7.11 and a 52-week high of $11.70. The business's fifty day simple moving average is $9.23 and its two-hundred day simple moving average is $9.24. The company has a market capitalization of $1.24 billion, a PE ratio of 16.96, a P/E/G ratio of 1.07 and a beta of 1.58.

Analyst Ratings Changes

AHCO has been the subject of a number of recent research reports. Truist Financial cut their price objective on AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a research report on Monday, May 12th. Royal Bank Of Canada reduced their target price on AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a report on Thursday, May 8th. Finally, Wall Street Zen upgraded AdaptHealth from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. Five investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of $13.40.

Insider Activity

In related news, Director David Solomon Williams III sold 8,200 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $9.73, for a total transaction of $79,786.00. Following the completion of the sale, the director directly owned 50,045 shares in the company, valued at approximately $486,937.85. This trade represents a 14.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.55% of the company's stock.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.